NWBO — Northwest Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Northwest Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	9.98	15.2	6.96	2.13	2.17
Prepaid Expenses
Total Current Assets	15.5	17.3	9.43	4.13	4.06
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14.6	19.9	19.6	21.5	20.4
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	32.9	40.2	31.3	27.9	26.7
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	382	134	126	45.2	68.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	396	164	136	74.9	106
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-363	-124	-105	-47.1	-79
Total Liabilities & Shareholders' Equity	32.9	40.2	31.3	27.9	26.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding